Document Detail


Tissue distribution and general safety of MnDPDP in male beagle dogs, with or without total common bile duct obstruction.
MedLine Citation:
PMID:  9245969     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Evaluation of the tissue distribution of manganese (Mn) and general safety in normal and cholestatic male beagle dogs after i.v. administration of mangafodipir trisodium (MnDPDP, Teslascan). MATERIAL AND METHODS: Male beagle dogs, with or without surgical obstruction of the common bile duct, received a single i.v. bolus injection of saline (control), or MnDPDP at doses of 10 or 50 mumol/kg b.w. and were sacrificed 1 or 7 days after treatment. Toxicity was assessed and tissue concentrations of Mn were measured. RESULTS: Increased tissue Mn concentrations were found in all dogs treated with MnDPDP and were greatest in those with biliary obstruction. Although Mn concentrations decreased with time in most tissues in each of the treated groups, this was not the case for the brain and adrenal glands in dogs with total biliary obstruction in which further increases in Mn concentrations were seen at the later time point. This suggested a re-distribution of Mn from the major body depots such as the liver. There were no effects of MnDPDP on clinical signs/behaviour, organ weights, histomorphology or clinical biochemistry. CONCLUSION: These findings indicate that a single clinical dose of 5 mumol/kg MnDPDP is likely to be well tolerated in patients with cholestasis.
Authors:
D Grant; K G Toft; I Martinsen; E Atzpodien
Related Documents :
19645219 - Pharmacokinetics of forsythoside after intravenous administration in beagle dogs.
21270789 - Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone...
21214109 - Severe tricuspid regurgitation in a patient receiving low-dose cabergoline for the trea...
21284699 - Riluzole pharmacokinetics in young patients with spinal muscular atrophy.
2721109 - Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricu...
21139249 - Effects of combination therapy with warfarin and bucolome for anticoagulation in patien...
19041369 - Potential mechanisms of neuroprotection induced by low dose total-body gamma-irradiatio...
2266789 - Pressor effect of ng-nitro-l-arginine in pentobarbital-anesthetized rats.
3808239 - Naloxone and experimental spinal cord injury: part 1. high dose administration in a sta...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Acta radiologica (Stockholm, Sweden : 1987)     Volume:  38     ISSN:  0284-1851     ISO Abbreviation:  Acta Radiol     Publication Date:  1997 Jul 
Date Detail:
Created Date:  1997-08-28     Completed Date:  1997-08-28     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8706123     Medline TA:  Acta Radiol     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  732-9     Citation Subset:  IM    
Affiliation:
Nycomed Imaging AS, Oslo, Norway. dgr@nycomed.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cholestasis, Extrahepatic / diagnosis,  metabolism*
Common Bile Duct* / pathology
Contrast Media / adverse effects,  pharmacokinetics*
Disease Models, Animal
Dogs
Drug Evaluation, Preclinical
Edetic Acid / adverse effects,  analogs & derivatives*,  diagnostic use,  pharmacokinetics
Ligation
Magnetic Resonance Imaging
Male
Manganese / adverse effects,  diagnostic use,  pharmacokinetics*
Prognosis
Pyridoxal Phosphate / adverse effects,  analogs & derivatives*,  diagnostic use,  pharmacokinetics
Safety
Tissue Distribution
Chemical
Reg. No./Substance:
0/Contrast Media; 119797-12-5/N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid; 54-47-7/Pyridoxal Phosphate; 60-00-4/Edetic Acid; 7439-96-5/Manganese
Comments/Corrections
Comment In:
Acta Radiol. 1997 Jul;38(4 Pt 2):623-5   [PMID:  9245954 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical implications of studies with MnDPDP in animal models of hepatic abnormalities.
Next Document:  Cardiovascular safety of MnDPDP and MnCl2.